T2 Biosystems Incの時価総額
T2 Biosystems Incの時価総額は何ですか。
T2 Biosystems Incの時価総額は10.39M$です。
時価総額の定義は何ですか。
時価総額は、取引された会社の発行済株式の市場価値であり、一定期間のb株式に発行済株式数を掛けたものに等しい。
As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.
Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.
The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.
NASDAQのセクタHealth Careにおける時価総額の企業と比べるT2 Biosystems Inc
T2 Biosystems Incは何をしますか。
t2 biosystems is developing innovative diagnostic products to improve patient health. with two fda-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, t2 biosystems is an emerging leader in the field of in vitro diagnostics. our initial development efforts target sepsis, hemostasis, bacteria and lyme disease, which are areas of significant unmet medical need. the company is utilizing its proprietary t2 magnetic resonance platform, or t2mr®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. at t2 biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. we invite you to apply for one of our open positions at www
T2 Biosystems Incと類似の時価総額
- Global Vectra Helicorpの時価総額は10.38M$です。
- Willow Biosciencesの時価総額は10.38M$です。
- MJの時価総額は10.38M$です。
- FinTech Chainの時価総額は10.38M$です。
- mVISE AGの時価総額は10.39M$です。
- VerifyMeの時価総額は10.39M$です。
- T2 Biosystems Incの時価総額は10.39M$です。
- Prime Intelligence Solutionsの時価総額は10.40M$です。
- Titon Plcの時価総額は10.40M$です。
- Akar Auto Industriesの時価総額は10.40M$です。
- Inditrade Capitalの時価総額は10.40M$です。
- HKBridgeの時価総額は10.41M$です。
- Chilean Metalsの時価総額は10.41M$です。